Carl B. Lauter

969 total citations
36 papers, 658 citations indexed

About

Carl B. Lauter is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carl B. Lauter has authored 36 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carl B. Lauter's work include Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Drug-Induced Adverse Reactions (3 papers). Carl B. Lauter is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Drug-Induced Adverse Reactions (3 papers). Carl B. Lauter collaborates with scholars based in United States. Carl B. Lauter's co-authors include Patrick L. Murphy, J Band, A. Martin Lerner, Elizabeth Bailey, Arnold J. Markowitz, Thomas J. Spira, Jonas A. Shulman, Renu B. Lal, Roberta A. Monson and Bonnie M. Jones and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Carl B. Lauter

32 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl B. Lauter United States 13 276 180 178 88 57 36 658
José Ramón Yuste Spain 13 253 0.9× 110 0.6× 143 0.8× 38 0.4× 44 0.8× 40 718
Rob J. Rentenaar Netherlands 15 447 1.6× 87 0.5× 69 0.4× 388 4.4× 34 0.6× 44 946
Emily West United States 13 289 1.0× 358 2.0× 115 0.6× 58 0.7× 94 1.6× 23 925
Michael C. Bach United States 16 485 1.8× 76 0.4× 246 1.4× 22 0.3× 97 1.7× 32 870
A. Safdar United States 11 343 1.2× 34 0.2× 342 1.9× 18 0.2× 35 0.6× 16 704
Roland V. Cellona United States 18 541 2.0× 39 0.2× 745 4.2× 119 1.4× 33 0.6× 31 871
M C Jordan United States 23 1.3k 4.6× 65 0.4× 177 1.0× 390 4.4× 31 0.5× 30 1.4k
John A. Mohr United States 16 238 0.9× 36 0.2× 186 1.0× 76 0.9× 34 0.6× 30 711
Margrit Carlson United States 8 177 0.6× 58 0.3× 311 1.7× 35 0.4× 17 0.3× 15 537
Julio C. Melo United States 12 143 0.5× 40 0.2× 194 1.1× 14 0.2× 130 2.3× 19 580

Countries citing papers authored by Carl B. Lauter

Since Specialization
Citations

This map shows the geographic impact of Carl B. Lauter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl B. Lauter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl B. Lauter more than expected).

Fields of papers citing papers by Carl B. Lauter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl B. Lauter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl B. Lauter. The network helps show where Carl B. Lauter may publish in the future.

Co-authorship network of co-authors of Carl B. Lauter

This figure shows the co-authorship network connecting the top 25 collaborators of Carl B. Lauter. A scholar is included among the top collaborators of Carl B. Lauter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl B. Lauter. Carl B. Lauter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Power, Laura E., Carl B. Lauter, Sandro Cinti, et al.. (2024). Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan. Clinical Infectious Diseases. 78(3). 637–645. 2 indexed citations
2.
Lynch, Stephen V., et al.. (2023). A Heart Gone Bananas: Allergy-Induced Coronary Vasospasm due to Banana (Kounis Syndrome). SHILAP Revista de lepidopterología. 2023. 1–3. 4 indexed citations
3.
Sims, Matthew, et al.. (2023). Falsely decreased vancomycin caused by rheumatoid factor: A case report. Clinica Chimica Acta. 548. 117460–117460. 3 indexed citations
4.
Lauter, Carl B., et al.. (2022). Post orgasmic illness syndrome successfully managed with antihistamine: A case report. Urology Case Reports. 45. 102189–102189. 5 indexed citations
5.
O’Connor, Daniel, et al.. (2022). Prognostic Value of SARS-CoV-2 Anti-RBD IgG Antibody Quantitation on Clinical Outcomes in Hospitalized COVID-19 Patients. International Journal of General Medicine. Volume 15. 5693–5700. 2 indexed citations
6.
Lauter, Carl B., et al.. (2018). Recurrent Idiopathic Anaphylaxis in a Woman After Suspected Food Poisoning. Infectious Diseases in Clinical Practice. 26(3). 138–140.
7.
Smith, James L., et al.. (2015). β-Blocker premedication does not increase the frequency of allergic reactions from coronary CT angiography: Results from the Advanced Cardiovascular Imaging Consortium. Journal of cardiovascular computed tomography. 9(4). 270–277. 6 indexed citations
8.
Snyder, Michael & Carl B. Lauter. (2010). Eosinophilic and neutrophilic leukemoid reaction in a woman with spindle cell sarcoma: a case report. Journal of Medical Case Reports. 4(1). 335–335. 6 indexed citations
9.
Lauter, Carl B.. (2006). Hypergammaglobulinemia, IgG2 Subclass Deficiency and Recurrent Infections in Adults. Journal of Allergy and Clinical Immunology. 117(2). S106–S106. 1 indexed citations
10.
Perri, Mary Beth, Ellie Hershberger, Mihaela Ionescu, Carl B. Lauter, & Marcus Zervos. (2002). In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin. Diagnostic Microbiology and Infectious Disease. 42(4). 269–271. 29 indexed citations
11.
Spira, Thomas J., Bonnie M. Jones, Janet K.A. Nicholson, et al.. (1993). Idiopathic CD4+ T-Lymphocytopenia -- An Analysis of Five Patients with Unexplained Opportunistic Infections. New England Journal of Medicine. 328(6). 386–392. 98 indexed citations
12.
Band, J, et al.. (1990). The Clinical Spectrum of Endophthalmitis: Incidence, Predisposing Factors, and Features Influencing Outcome. The Journal of Infectious Diseases. 162(1). 115–120. 179 indexed citations
13.
DeRidder, Peter H., et al.. (1989). Candida cellulitis: a complication of percutaneous endoscopic gastrostomy. Gastrointestinal Endoscopy. 35(6). 571–572. 7 indexed citations
14.
Lauter, Carl B., et al.. (1982). Spiking Fever and Rash in a Postpartum Patient. Hospital Practice. 17(11). 188–190. 1 indexed citations
15.
Lauter, Carl B.. (1980). Herpes Simplex Encephalitis: A Great Clinical Challenge. Annals of Internal Medicine. 92(5). 696–698. 5 indexed citations
16.
Lauter, Carl B., et al.. (1978). Antiherpesvirus Activity in Human Sera and Urines after Administration of Adenine Arabinoside. Journal of Clinical Investigation. 62(6). 1142–1153. 16 indexed citations
17.
Lauter, Carl B., Elizabeth Bailey, & A. Martin Lerner. (1976). Microbiologic Assays and Neurological Toxicity during Use of Adenine Arabinoside in Humans. The Journal of Infectious Diseases. 134(1). 75–79. 25 indexed citations
18.
Madrazo, Armando, et al.. (1975). Massive Empyema Due to Citrobacter Diversus. CHEST Journal. 68(1). 104–106. 6 indexed citations
19.
Lauter, Carl B., Elizabeth Bailey, & A. Martin Lerner. (1974). Assessment of Cytosine Arabinoside as an Antiviral Agent in Humans. Antimicrobial Agents and Chemotherapy. 6(5). 598–602. 16 indexed citations
20.
Lauter, Carl B., et al.. (1973). The Nitroblue Tetrazolium Test and Acute Myocardial Infarction. Annals of Internal Medicine. 79(1). 59–62. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Ramón Yuste Breakdown of academic impact, for papers by Rob J. Rentenaar Breakdown of academic impact, for papers by Emily West Breakdown of academic impact, for papers by Michael C. Bach Breakdown of academic impact, for papers by A. Safdar Breakdown of academic impact, for papers by Roland V. Cellona Breakdown of academic impact, for papers by M C Jordan Breakdown of academic impact, for papers by John A. Mohr Breakdown of academic impact, for papers by Margrit Carlson Breakdown of academic impact, for papers by Julio C. Melo
Rankless by CCL
2026